Stockreport

Tiziana acquires IP for nanoparticle formulation of chemo agent actinomycin [Seeking Alpha]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF Tiziana Life Sciences (TLSA-6.9%agreementUnder the terms of the deal, Tiziana will pay Rasna $120K upfront plus up to $630K in milestones.Actinomycin D was originally ap [Read more]